Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma.
The global Digital Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of 27.9% during 2019-2025.
Digital Therapeutics Market growth is driven by the incidence of preventable chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and a number of benefits offered by digital therapeutics, such as their abilities to induce behavioral change, improve drug adherence, patient convenience, and user-friendliness. Furthermore, government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus to the growth of this market. The relatively untapped Asia-Pacific market and unexplored therapeutic applications have opened an array of opportunities for the growth of the market. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.
Get PDF template of this report at https://www.qyresearch.com/sample-form/form/983484/global-digital-therapeutics-depth-analysis-report-
This report focuses on Digital Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Proteus Digital Health, Inc.
Omada Health, Inc.
Canary Health Inc.
Mango Health Inc.
Segment by Regions
Segment by Type
Segment by Application
Request Customization of Report at https://www.qyresearch.com/customize-request/form/983484/global-digital-therapeutics-depth-analysis-report-
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.